Literature DB >> 25934461

Hepatitis B virus epidemiology.

Jennifer H MacLachlan1, Benjamin C Cowie2.   

Abstract

The epidemiology of hepatitis B virus (HBV) infection is geographically diverse, with population prevalence, age and mode of acquisition, and likelihood of progression to chronic infection mutually interdependent. The burden of chronic HBV infection is increasingly being recognized, with cirrhosis and liver cancer attributable to HBV continuing to increase. The outcomes of chronic HBV infection are affected by a range of factors, including viral genotype, the presence of coinfections with other blood-borne viruses, and the impact of other causes of liver disease. The increased recognition of HBV infection as a leading cause of death globally has resulted in the development of new structures and policies at the international level; immediate attention to implementing these strategies is now required.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25934461      PMCID: PMC4448582          DOI: 10.1101/cshperspect.a021410

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  73 in total

Review 1.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

Review 2.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

3.  The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Helen M Chun; Nancy F Crum-Cianflone; Anuradha Ganesan; Amy C Weintrob; R Vincent Barthel; Robert J O'Connell; Brian K Agan
Journal:  Am J Epidemiol       Date:  2010-11-04       Impact factor: 4.897

4.  Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.

Authors:  Janaki Amin; Matthew G Law; Mark Bartlett; John M Kaldor; Gregory J Dore
Journal:  Lancet       Date:  2006-09-09       Impact factor: 79.321

Review 5.  Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.

Authors:  Lisa Y Cho; Jae Jeong Yang; Kwang-Pil Ko; Boyoung Park; Aesun Shin; Min Kyung Lim; Jin-Kyoung Oh; Sohee Park; Yoon Jun Kim; Hai-Rim Shin; Keun-Young Yoo; Sue K Park
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

6.  An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes.

Authors:  V A Arankalle; S Gandhi; K S Lole; M S Chadha; G M Gupte; M U Lokhande
Journal:  J Viral Hepat       Date:  2010-11-26       Impact factor: 3.728

Review 7.  Hepatitis B virus genotypes.

Authors:  Anna Kramvis; Michael Kew; Guido François
Journal:  Vaccine       Date:  2005-03-31       Impact factor: 3.641

8.  The influence of age on the development of the hepatitis B carrier state.

Authors:  W J Edmunds; G F Medley; D J Nokes; A J Hall; H C Whittle
Journal:  Proc Biol Sci       Date:  1993-08-23       Impact factor: 5.349

9.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Authors:  Xiaofeng Liang; Shengli Bi; Weizhong Yang; Longde Wang; Gang Cui; Fuqiang Cui; Yong Zhang; Jianhua Liu; Xiaohong Gong; Yuansheng Chen; Fuzhen Wang; Hui Zheng; Feng Wang; Jing Guo; Zhiyuan Jia; Jingchen Ma; Huaqing Wang; Huiming Luo; Li Li; Shuigao Jin; Stephen C Hadler; Yu Wang
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

10.  A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China.

Authors:  J Shi; L Zhu; S Liu; W-F Xie
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

View more
  75 in total

1.  Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.

Authors:  Mei Song; Yinyan Sun; Wenhui Li; Ji Tian; Wenhui He; Guangwei Xu; Zhiyi Jing
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 2.  Viral hepatitis and pregnancy.

Authors:  Norah A Terrault; Miriam T Levy; Ka Wang Cheung; Gonzague Jourdain
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-12       Impact factor: 46.802

Review 3.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 4.  The use of humanized mice for studies of viral pathogenesis and immunity.

Authors:  Florian Douam; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2018-03-28       Impact factor: 7.090

Review 5.  Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.

Authors:  Jiang Su; Li Long; Kun Zou
Journal:  Clin Rheumatol       Date:  2018-04-10       Impact factor: 2.980

Review 6.  Plant-based vaccines for animals and humans: recent advances in technology and clinical trials.

Authors:  Natsumi Takeyama; Hiroshi Kiyono; Yoshikazu Yuki
Journal:  Ther Adv Vaccines       Date:  2015-09

7.  Moderate Heat-Assisted Gene Electrotransfer for Cutaneous Delivery of a DNA Vaccine Against Hepatitis B Virus.

Authors:  Chelsea Edelblute; Cathryn Mangiamele; Richard Heller
Journal:  Hum Gene Ther       Date:  2021-06-09       Impact factor: 5.695

8.  Prevalence of Hepatitis B Virus Among Pregnant Women on Antenatal Care Follow-Up at Mizan-Tepi University Teaching Hospital and Mizan Health Center, Southwest Ethiopia.

Authors:  Zufan Asaye; Temesgen Aferu; Adane Asefa; Desalegn Feyissa; Tolcha Regasa; Oliyad Kebede; Diriba Feyisa; Mulugeta Feyisa
Journal:  Int J Gen Med       Date:  2021-01-18

Review 9.  Infections at the nexus of metabolic-associated fatty liver disease.

Authors:  Robim M Rodrigues; Tamara Vanhaecke; Joost Boeckmans; Matthias Rombaut; Thomas Demuyser; Baptist Declerck; Denis Piérard; Vera Rogiers; Joery De Kock; Luc Waumans; Koen Magerman; Reinoud Cartuyvels; Jean-Luc Rummens
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

10.  Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.

Authors:  Tanvir Hossain; Shahla Romal; Elisa De Crignis; Fabrizia Carofiglio; Panagiotis Moulos; Mir Mubashir Khalid; Shringar Rao; Ameneh Bazrafshan; Monique Ma Verstegen; Farzin Pourfarzad; Christina Koutsothanassis; Helmuth Gehart; Tsung Wai Kan; Robert-Jan Palstra; Charles Boucher; Jan Nm IJzermans; Meritxell Huch; Sylvia F Boj; Robert Vries; Hans Clevers; Luc Jw van der Laan; Pantelis Hatzis; Tokameh Mahmoudi
Journal:  Elife       Date:  2021-07-30       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.